Barclays has downgraded Keurig Dr Pepper Inc (KDP) to Equal-Weight from Overweight, effective September 23, 2025. The current share price stands at $27.71.
This decision underscores a more cautious outlook on the company, potentially reflecting concerns over competitive pressures, market conditions, or execution risks that could influence performance. Keurig Dr Pepper, headquartered in Burlington, Massachusetts, engages in the manufacture, marketing, distribution, and sales of non-alcoholic beverages. The company boasts a diverse portfolio, including brands such as Dr Pepper, Snapple, and Canada Dry.
As of November 20, 2025, Keurig Dr Pepper holds a market capitalization of $37.0 billion with a P/E ratio of 23.39 and an EPS of 1.16. The company's dividend yield is notably high at 342.1%. Upcoming earnings reports are scheduled for July 22, 2026, with an EPS estimate of $0.54 and revenue expectations of $4.4 billion.
Analyst ratings provide valuable insights but should be considered alongside company fundamentals, competitive positioning, and industry trends. The current analyst consensus remains a Buy, with 5 Strong Buy, 9 Buy, 8 Hold, and 1 Sell ratings among 23 total analysts. Recent actions include a downgrade from BNP Paribas to Underperform on September 22, 2025, and a maintained Overweight rating from Piper Sandler on September 17, 2025.
Such decisions reflect the dynamic nature of market assessments and the varying opinions among analysts regarding Keurig Dr Pepper's future prospects.